Product

Daclatasvir + Sofosbuvir

1 clinical trial

1 indication

Indication

Chronic hepatitis C virus infection

Clinical trial

Clinical Pharmacokinetics, Safety and Efficacy Study of Daclatasvir/Sofosbuvir in Adolescents Aged 12 to 18 Years Old With Hepatitis C Virus: A Preliminary Study

Status: Recruiting, Estimated PCD: 2023-04-01